|
Clinical study of AdV-tk radiogene therapy for malignant glioma
|
5R44CA107745-05
|
$510,001
|
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-16
|
$281,080
|
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Persistent HPV in Women at Risk for Cervix Cancer
|
5U01CA078527-12
|
$590,661
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Multiplex approach to DNA methylation assays in exhaled breath condensate
|
5R03CA132145-02
|
$83,000
|
|
HAN, WEIGUO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EMT, Extravasation and metastasis by N-Cadherin signaling
|
1R01CA135061-01A1
|
$344,450
|
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Ricin-Mechanism, Transition State and Inhibitor Design
|
5R01CA072444-13
|
$374,122
|
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
miRNA Profiling in Fixed Cancer Samples
|
5R44CA118785-03
|
$622,242
|
|
BROWN, DAVID
|
AMBION DIAGNOSTICS, INC.
|
|
Molecular Biology in Clinical Oncology Workshop
|
5R25CA057732-18
|
$303,047
|
|
Kaelin, William
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Storytelling to Promote Colorectal Screening in Primary Care Clinics
|
7R01CA116467-04
|
$409,128
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Microfluidics-Based Platform for Screening Combinatorial Drug Treatments
|
5R21CA131891-02
|
$163,887
|
|
Rege, Kaushal
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Targeted Gene Therapy for Lymphoma
|
5R01CA113454-04
|
$263,186
|
|
SMITH, BRUCE
|
AUBURN UNIVERSITY AT AUBURN
|
|
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
|
5R01CA168912-04
|
$320,588
|
$320,588
|
HE, YUKAI
|
AUGUSTA UNIVERSITY
|
|
TREM-1 and Its Implications to Cancer
|
5R01CA172230-04
|
$315,400
|
$315,400
|
HORUZSKO, ANATOLIJ
|
AUGUSTA UNIVERSITY
|
|
Role of heat shock transcription factor HSF1 in tumoroginesis
|
5R01CA062130-22
|
$556,510
|
$556,510
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
Development of cell-free DNA assays for HCC screening and liquid biopsy
|
5R01CA202769-02
|
$472,981
|
$472,981
|
SU, YING-HSIU
|
BARUCH S. BLUMBERG INSTITUTE
|
|
Roll Your Own (RYO) Cigarettes: Prevalence, Smoking Behavior and Toxin Exposure
|
1R01CA138973-01
|
$407,794
|
|
Pickworth, Wallace
|
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
The Epidemiologic Effects of HAART on HIV-related Anal Cancer and Anal Dysplasia
|
5K23CA124318-04
|
$137,700
|
|
Chiao, Elizabeth
|
BAYLOR COLLEGE OF MEDICINE
|
|
Progesterone Receptor Binding to Specific DNA Sequences
|
2R01CA046938-21A1
|
$264,008
|
|
EDWARDS, DEAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
5R01CA190776-03
|
$636,729
|
$636,729
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Breast Cancer Research Training Program
|
5T32CA090221-07
|
$263,406
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genetic analysis of mouse chromosome 11
|
5R01CA115503-04
|
$475,508
|
|
Justice, Monica
|
BAYLOR COLLEGE OF MEDICINE
|
|
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA
|
5R01CA086832-07
|
$279,192
|
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pilot and Feasibility Evaluation of a Walking School Bus Program Intervention for
|
5R21CA133418-02
|
|
|
Mendoza, Jason
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$3,550
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$3,566
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$3,668
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$7,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$97,594
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Research Training Program
|
5T32CA115303-04
|
$377,169
|
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurobehavioral Late-Effects in Pediatric Brain Tumors
|
7R01CA112182-05
|
$506,986
|
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
DNA Repair and Replication Re-start in vivo
|
2R01CA085777-06A2
|
$300,598
|
|
Rosenberg, Susan
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
5R01CA131027-02
|
$318,513
|
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
De facto Target of Histone Deacetylase Inhibitors
|
1R21CA215591-01
|
$172,369
|
$172,369
|
SUN, ZHENG
|
BAYLOR COLLEGE OF MEDICINE
|
|
MiRNAs in hepatocellular carcinoma development and treatment
|
2R01CA139158-06A1
|
$410,875
|
$410,875
|
HUANG, WENDONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$1,466
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$2,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$48,934
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-02
|
$474,276
|
$161,254
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-04
|
|
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
AKT pathway as a therapeutic tumor vessel target
|
5R01CA131064-02
|
$402,342
|
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Downstream of Akt in the tumor vessel
|
5R01CA131152-02
|
$459,978
|
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Nicotine in Lung Carcinogenesis
|
5R01CA124490-03
|
$323,000
|
|
CHEN, CHANGYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-15
|
$99,433
|
$19,887
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Intraoperative Near-Infrared Fluorescence Imaging
|
5R01CA115296-05
|
$1,235,683
|
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr
|
5U01CA113913-05
|
$843,497
|
|
SANDA, MARTIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Analysis of BRCA1 recombination functions
|
2R01CA095175-06A1
|
$304,354
|
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MAGIC ROUNDABOUT (MRB), A TUMOR ENDOTHELIAL MARKER
|
5K01CA104700-05
|
$153,629
|
|
SETH, PANKAJ
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Suppression of FOXO3a as a determinant in Bcr-Abl-mediated transformation
|
5F32CA132365-02
|
$50,054
|
|
Singh, Amrik
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of NFAT and NFAT-Induced Genes in Carcinoma
|
2R01CA096710-06A2
|
$304,354
|
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Total relevant funding to Liver Cancer for this search: $78,038,263
|